Seeking Alpha

Mylan (MYL +0.9%) gets a boost today from an upgrade to Outperform at Leerink Swann, citing a...

Mylan (MYL +0.9%) gets a boost today from an upgrade to Outperform at Leerink Swann, citing a better outlook for EpiPen sales and optimism over the company's 2013 guidance. The firm ups its price target to $30 from $26.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs